Hypersensitivity Syndrome Associated with Efavirenz Therapy
Open Access
- 1 January 2000
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 30 (1) , 227-228
- https://doi.org/10.1086/313629
Abstract
Hypersensitivity syndrome, also called DRESS (drug rash with eosinophilia and systemic symptoms) syndrome, is a life-threatening reaction that typically includes skin rash, fever, multivisceral involvement (lymphadenopathy, hepatitis, interstitial nephritis, pneumonia, and myocarditis), and hematologic abnormalities, especially eosinophilia and mononucleosis-like atypical lymphocytosis [1]. Recently, cases have been associated with nevirapine, a nonnucleoside HIV reverse transcriptase inhibitor [2, 3]. We describe a case of hypersensitivity syndrome in an HIV type 1-infected patient treated with efavirenz.Keywords
This publication has 4 references indexed in Scilit:
- Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adultsAIDS, 1998
- DRESS (Drug Rash with Eosinophilia and Systemic Syndrome Associated with Nevirapine TherapyClinical Infectious Diseases, 1998
- Hypersensitivity syndrome associated with zalcitabine therapyThe Lancet, 1996
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994